Literature DB >> 16150497

High level of cross-reactivity in influenza virus hemagglutinin-specific CD4+ T-cell response: implications for the initiation of autoimmune response in multiple sclerosis.

Silva Markovic-Plese1, Bernhard Hemmer, Yingdong Zhao, Richard Simon, Clemencia Pinilla, Roland Martin.   

Abstract

Viral infections play a role in shaping and maintaining the peripheral T-cell repertoire, as well as in the initiation of autoimmune response via mechanisms of molecular mimicry. In this study, we addressed the flexibility of T-cell receptor (TCR) recognition and the degree of structural and sequence homology required for cross-reactive immune response in the induction of autoimmune response. We studied the extent of cross-reactivity of a CD4+T-cell clone (TCC) specific for the immunodominant influenza virus hemagglutinin (Flu-HA) peptide derived from a patient with multiple sclerosis (MS) using positional scanning synthetic peptide combinatorial libraries (PS-SCL). We documented cross-reactivity against 14 Flu-HA variants, 11 viral, 15 human, and 3 myelin-derived peptides. Moreover, we identified six naturally occurring peptides with higher stimulatory potency than the native ligand, implicating high potential for cross-reactivity even for a virus-specific memory TCC. Our study demonstrates that flexibility of TCR recognition is present even in a clone with a high degree of TCR specificity for an infectious agent. The results have implications for vaccine design and for antigen-specific treatment strategies for autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16150497     DOI: 10.1016/j.jneuroim.2005.07.014

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  24 in total

Review 1.  Cross-immune tolerance: conception and its potential significance on transplantation tolerance.

Authors:  Yong Zhao; Xianchang Li
Journal:  Cell Mol Immunol       Date:  2009-12-23       Impact factor: 11.530

Review 2.  Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases.

Authors:  Carlo Perricone; Fulvia Ceccarelli; Gideon Nesher; Elisabetta Borella; Qasim Odeh; Fabrizio Conti; Yehuda Shoenfeld; Guido Valesini
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

3.  Peptide sharing between influenza A H1N1 hemagglutinin and human axon guidance proteins.

Authors:  Guglielmo Lucchese; Giovanni Capone; Darja Kanduc
Journal:  Schizophr Bull       Date:  2013-01-31       Impact factor: 9.306

Review 4.  Phage display--a powerful technique for immunotherapy: 1. Introduction and potential of therapeutic applications.

Authors:  Justyna Bazan; Ireneusz Całkosiński; Andrzej Gamian
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

Review 5.  CD46 plasticity and its inflammatory bias in multiple sclerosis.

Authors:  Siobhan Ni Choileain; Anne L Astier
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2011-01-26       Impact factor: 4.291

6.  Human CD4+ T cell response to human herpesvirus 6.

Authors:  Maria-D Nastke; Aniuska Becerra; Liusong Yin; Omar Dominguez-Amorocho; Laura Gibson; Lawrence J Stern; J Mauricio Calvo-Calle
Journal:  J Virol       Date:  2012-02-22       Impact factor: 5.103

Review 7.  Autoimmune T cell responses in the central nervous system.

Authors:  Joan Goverman
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

8.  A molecular view of multiple sclerosis and experimental autoimmune encephalitis: what can we learn from the epitope data?

Authors:  Kerrie Vaughan; Bjoern Peters; Kevin C O'Connor; Roland Martin; Alessandro Sette
Journal:  J Neuroimmunol       Date:  2013-12-12       Impact factor: 3.478

9.  Identification of B cell and T cell epitopes using synthetic peptide combinatorial libraries.

Authors:  Clemencia Pinilla; Jon R Appel; Valeria Judkowski; Richard A Houghten
Journal:  Curr Protoc Immunol       Date:  2012-11

10.  Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups.

Authors:  Hans-Georg Rammensee; Cécile Gouttefangeas; Sonja Heidu; Reinhild Klein; Beate Preuß; Juliane Sarah Walz; Annika Nelde; Sebastian P Haen; Michael Reth; Jianying Yang; Ghazaleh Tabatabai; Hans Bösmüller; Helen Hoffmann; Michael Schindler; Oliver Planz; Karl-Heinz Wiesmüller; Markus W Löffler
Journal:  Vaccines (Basel)       Date:  2021-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.